Drug
Insulin Glargine clinical trials
Also written Lantus, Glargine, LY2963016 and Basaglar.
Includes 3 studies of MK-1293 and 1 study of MYL-1501D.
- studies test it
- 295
- open now
- 5
- in phase 3
- 90
- first study started
- 2000
Keep track of what changes. Save the Insulin Glargine studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
295 studies that test it; most in 2011 (26)
| Year | Studies |
|---|---|
| 2000 | 1 |
| 2001 | 7 |
| 2002 | 10 |
| 2003 | 16 |
| 2004 | 15 |
| 2005 | 15 |
| 2006 | 16 |
| 2007 | 8 |
| 2008 | 12 |
| 2009 | 18 |
| 2010 | 22 |
| 2011 | 26 |
| 2012 | 18 |
| 2013 | 12 |
| 2014 | 12 |
| 2015 | 16 |
| 2016 | 13 |
| 2017 | 8 |
| 2018 | 10 |
| 2019 | 9 |
| 2020 | 4 |
| 2021 | 4 |
| 2022 | 10 |
| 2023 | 4 |
| 2024 | 6 |
| 2025 | 2 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 1
- Phase 1
- 28
- Phase 2
- 6
- Phase 3
- 90
- Phase 4
- 148
- No phase
- 22
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 188 · Other 107
Sanofi (116) · Novo Nordisk A/S (30) · Eli Lilly and Company (25) · Emory University (9) · Merck Sharp & Dohme LLC (4) · Life for a Child Program, Diabetes Australia (3) · Ain Shams University (3) · University of Colorado, Denver (3)
Often tested with
Tested in the same studies.
Insulin glulisine (25) · Lixisenatide (20) · Metformin (19) · Insulin Aspart (18) · Insulin degludec (17) · Insulin Detemir (15) · Insulin, Isophane (8) · Insulin (7)
Studies
Open first, then newest update. How each study uses Insulin Glargine is read from its arms, and is right about nine times in ten.
Testing it · 295
- iGlarLixi CGM Study in Chinese T2D Individuals After OADsRecruitingPhase 4SanofiNCT06671587Written as iGlarLixi (insulin glargine/lixisenatide)
- Regimen Transition After Short-Term Intensive Insulin Therapy in Type 2 DiabetesNot yet recruitingPhase 4Yanbing LiNCT07173712Written as Insulin Glargine (HOE901 - U300)
- Evaluation of the Efficacy and Safety of GLP-1 Receptor Agonist Therapy In Steroid-Induced DiabetesEnrolling by invitationPhase 4Medical University of WarsawNCT07117240Written as lixisenatide + glargine
- RCT Glargine vs NPH for Treatment of DM in PregnancyRecruitingPhase 3Loyola UniversityNCT06619301Written as Insulin glargine
- Comparison of Diabetes Retinopathy Among Type 2 Diabetic Patients Treated With Different RegimensRecruitingEarly Phase 1Third Affiliated Hospital, Sun Yat-Sen UniversityNCT02587741Written as Lantus
- A Clinical Trial Comparing the Efficacy and Safety of Exubera® and Lantus®CompletedPhase 4PfizerNCT00391027Written as Insulin Glargine (Lantus®)
- A Research Study to See How Switching From a Daily Basal Insulin to a New Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine in Adults With Type 2 DiabetesCompletedPhase 3Novo Nordisk A/SNCT06340854Written as Insulin glargine
- Glycemic Control After Antenatal Corticosteroids in Women With Pregestational and Gestational DiabetesActive, not recruitingPhase 2University of Alabama at BirminghamNCT04542148Written as Up-Titration of Home Insulin
- Effects of iGlarLixi Versus iGlar on Liver Fat Content in Patients With Type 2 Diabetes Mellitus Combined With Metabolic Dysfunction-associated Steatotic Liver DiseaseActive, not recruitingPhase 4The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolNCT07274644Written as iGlarLixi
- A Research Study to See How Well New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Levels in People With Type 2 Diabetes (T2D), Compared to Daily Insulin Glargine (COMBINE 4)CompletedPhase 3Novo Nordisk A/SNCT06269107Written as Insulin glargine
- Effect of Topical Insulin on Healing Rate of Pemphigus LesionsCompletedPhase 2Alexandria UniversityNCT07461103Written as insulin glargine
- A Comparative Effectiveness Study of Major Glycemia-lowering Medications for Treatment of Type 2 DiabetesCompletedPhase 3GRADE Study GroupNCT01794143Written as Insulin (glargine)
- A Study Comparing HR17031 With Insulin Glargine in Patients With Type 2 DiabetesCompletedPhase 3Jiangsu HengRui Medicine Co., Ltd.NCT06881264Written as insulin glargine
- iGlarLixi vs IDegAsp in Chinese Participants After OAD(s)CompletedPhase 3SanofiNCT05413369Written as Insulin glargine/Lixisenatide
- Evaluation of the Safety and Efficacy of Insulin Glargine 300 U/ml (Gla-300) in Insulin-naïve Patients With Type 2 Diabetes Mellitus Uncontrolled on Oral Antihyperglycemic DrugsCompletedPhase 4SanofiNCT04980027Written as Insulin glargine (U300)
- Human Versus Analogue Insulin for Youth With Type 1 Diabetes in Low-Resource SettingsCompletedPhase 4Jing LuoNCT05614089Written as Insulin Glargine
- Effect of Soliqua 100/33 on Time in Range From Continuous Glucose Monitoring in Insulin-naive Patients With Very Uncontrolled Type 2 Diabetes MellitusCompletedPhase 4SanofiNCT05114590Written as Insulin glargine/Lixisenatide
- Gla-300 and IDeg-100 in Insulin-Naïve People With Type 2 Diabetes Mellitus and Renal ImpairmentTerminatedPhase 4SanofiNCT05552859Written as Insulin glargine 300 U/mL
- Impact of Introducing Basaglar Insulin to the Treatment Regimen of Youth With Diabetes in PakistanCompletedPhase 4Life for a Child Program, Diabetes AustraliaNCT06717191Written as biosimilar insulin glargine
- Remote And Decentralised Innovative Approaches to Clinical Trials (RADIAL)CompletedPhase 4Mira ZuidgeestNCT05780151Written as Toujeo
See all 295 studies that test Insulin Glargine →
Given in every arm · 69 — Insulin Glargine is usual care beside what is tested
- A Study of LY900014 in Adult Participants With Type 2 Diabetes Mellitus in IndiaCompletedPhase 4Eli Lilly and CompanyNCT06370715Written as Insulin Glargine
- Efficacy and Safety of THDB0206 Compared to Insulin Lispro Injection in Participants With Type 1 DiabetesCompletedPhase 3Tonghua Dongbao Pharmaceutical Co.,LtdNCT07282054Written as Insulin Glargine
- Evaluation of Insulin Glulisine (GP40321) Compared to Insulin Glulisine (Apidra® SoloStar®) in Type 1 Diabetes Mellitus PatientsCompletedPhase 3GeropharmNCT07070752Written as RinGlar®
- Afrezza® INHALE-1 Study in PediatricsCompletedPhase 3Mannkind CorporationNCT04974528Written as Basal Insulin
- Comparison of SAR341402 to NovoLog in Adult Patients With Type 1 Diabetes Mellitus Also Using Insulin GlargineCompletedPhase 3SanofiNCT03874715Written as Insulin glargine U100
- Novolog vs. Fiasp Insulin in Non-critically Ill Hospitalized Patients With Type 2 Diabetes MellitusCompletedPhase 3Boston Medical CenterNCT04460326Written as Insulin glargine
- FLuctuATion Reduction With inSULin and Glp-1 Added togetheR (FLAT-SUGAR)CompletedPhase 4University of WashingtonNCT01524705Written as Insulin Glargine
- Simplified Insulin Regimen for the ElderlyTerminatedPhase 4University of MiamiNCT03660553Written as Insulin Glargine
- SITAgliptin Plus GLARgine to Glycemic Control in the Hospital Setting (SITAGLAR-H)CompletedPhase 4Hospital de Especialidades, Centro Medico Nacional "La Raza", Instituto Mexicano del Seguro SocialNCT05579119Written as Glargine
- A Research Study of How Overdosing of a New Once Weekly Medicine NNC0148-0287 C (Insulin 287) Influences the Blood Sugar Level in People With Type 2 DiabetesCompletedPhase 1Novo Nordisk A/SNCT03945656Written as Insulin glargine
- A Study of Dulaglutide (LY2189265) in Chinese Participants With Type 2 DiabetesCompletedPhase 3Eli Lilly and CompanyNCT04591626Written as Insulin Glargine
- A Study of Mealtime Insulin LY900014 in Participants With Type 2 Diabetes Using Continuous Glucose Monitoring (PRONTO-Time in Range)CompletedPhase 3Eli Lilly and CompanyNCT04605991Written as Insulin Glargine
- A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 1 DiabetesCompletedPhase 3Eli Lilly and CompanyNCT03952130Written as Insulin Glargine
- A Research Study to Compare Semaglutide to Insulin Aspart, When Taken Together With Metformin and Insulin Glargine, in People With Type 2 DiabetesCompletedPhase 3Novo Nordisk A/SNCT03689374Written as Insulin glargine U100
- Comparison of SAR341402 to NovoLog/NovoRapid in Adult Patients With Diabetes Mellitus Also Using Insulin GlargineCompletedPhase 3SanofiNCT03211858Written as Insulin glargine (HOE901)
- Remission Evaluation of a Metabolic Intervention in Type 2 Diabetes With Sitagliptin (REMIT-Sita)CompletedPhase 3Population Health Research InstituteNCT02623998Written as insulin glargine
- A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 2 DiabetesCompletedPhase 3Eli Lilly and CompanyNCT03952143Written as Insulin Glargine
- Efficacy and Safety of Sotagliflozin Versus Placebo in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control While Taking Insulin Alone or With Other Oral Antidiabetic AgentsCompletedPhase 3Lexicon PharmaceuticalsNCT03285594Written as Insulin glargine (HOE901)
- A Research Study of How Different Amounts of a New Medicine NNC0148-0287 C (Insulin 287) Works on the Blood Sugar of People Who Are Japanese With Type 1 Diabetes When Given Once a WeekCompletedPhase 1Novo Nordisk A/SNCT03766854Written as Insulin glargine U100
- Remission Evaluation of a Metabolic Intervention in Type 2 Diabetes With ForxigaCompletedPhase 4Population Health Research InstituteNCT02561130Written as insulin glargine
Showing 20 of 69.
As the comparator · 146 — what is tested is compared with Insulin Glargine
- CGM-guided Patch Pump vs Basal-Bolus Injection for Steroid-Induced Hyperglycemia in Sudden Sensorineural Hearing Loss: SHIP TrialNot yet recruitingNot applicableHallym UniversityNCT07652528Written as Insulin Glargine U-100 (Lantus)
- Single vs Multi-Dose Insulin for Glycemic Control (SUGAR)RecruitingNot applicableRutgers, The State University of New JerseyNCT07171684Written as Insulin glargine + insulin lispro
- Liraglutide-bolus vs Glargine-bolus Therapy in Overweight/Obese Type 2 Diabetes Patients (LiraGooD)RecruitingPhase 4The First Affiliated Hospital of Xiamen UniversityNCT03087032Written as insulin glargine
- The Effect of Short-term Insulin Intensive Therapy Based on the Application of Insulin Pump and Real-time Dynamic Glucose Monitoring Technology on Reversing the Newly Diagnosed Type 2 DiabetesRecruitingPhase 4Sun Yat-sen UniversityNCT06127433Written as Insulin Glargine
- Effects of Tirzepatide and Insulin Glargine on Glucolipid Metabolism and Brain Function in Patients With Type 2 DiabetesRecruitingPhase 4Nanjing First Hospital, Nanjing Medical UniversityNCT05553093Written as Insulin Glargine
- A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 DiabetesActive, not recruitingPhase 3Novo Nordisk A/SNCT07076199Written as Insulin glargine
- Oral Anti Diabetic Agents in the HospitalTerminatedPhase 4Emory UniversityNCT04416269Written as Basal bolus insulin
- This Study Is To Determine If Inhaled Insulin Is Effective In Treating Type 2 Diabetes MellitusCompletedPhase 4PfizerNCT00418522Written as Insulin glargine
- Efficacy and Safety of SHR-3167 and Insulin Glargine in Type 2 Diabetes SubjectsCompletedPhase 2Jiangsu HengRui Medicine Co., Ltd.NCT06688123Written as Insulin glargine
- Comparing the Safety and Efficacy of Insulin GLARGINE and DEGLUDEC in Glucocorticoid Induced HYPERGLYCEMIA in Hospitalized Patients".CompletedPhase 4Max Healthcare Insititute LimitedNCT07599891Written as Glargine insulin
- A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular RiskCompletedPhase 3Eli Lilly and CompanyNCT05803421Written as Insulin Glargine
- A Trial Comparing HR17031 With Insulin Glargine in Patients With Type 2 DiabetesCompletedPhase 3Jiangsu HengRui Medicine Co., Ltd.NCT06871761Written as insulin glargine
- A Research Study to Compare Two Types of Insulin, a New Weekly Insulin, Insulin Icodec and an Available Daily Insulin, Insulin Glargine, Both in Combination With Mealtime Insulin, in People With Type 2 Diabetes Who Use Daily Insulin and Mealtime Insulin (ONWARDS 4)CompletedPhase 3Novo Nordisk A/SNCT04880850Written as Insulin glargine
- A Research Study to Compare Two Types of Insulin, a New Insulin, Insulin Icodec and an Available Insulin, Insulin Glargine, in People With Type 2 Diabetes Who Have Not Used Insulin BeforeCompletedPhase 3Novo Nordisk A/SNCT04460885Written as Insulin glargine
- A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Insulin Glargine Taken Daily With Insulin Aspart (COMBINE 3)CompletedPhase 3Novo Nordisk A/SNCT05013229Written as Insulin glargine
- A Phase III Clinical Study to Assess the Efficacy and Safety of GZR4 in Insulin-naive Subjects With Type 2 Diabetes Mellitus (T2DM)Active, not recruitingPhase 3Gan & Lee Pharmaceuticals.NCT06767735Written as Insulin Glargine U100
- A Study of Insulin Efsitora Alfa (LY3209590) Compared to Glargine in Adult Participants With Type 2 Diabetes Who Are Starting Basal Insulin for the First Time (QWINT-1)CompletedPhase 3Eli Lilly and CompanyNCT05662332Written as Insulin Glargine
- Effects of Modulators of Gluconeogenesis, Glycogenolysis and Glucokinase ActivityActive, not recruitingPhase 3University of Alabama at BirminghamNCT05098470Written as Insulin Glargine
- To Compare the Efficacy and Safety of INS068 and Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin.CompletedPhase 3Jiangsu HengRui Medicine Co., Ltd.NCT05702073Written as Insulin Glargine
- To Compare the Efficacy and Safety of INS068 and Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Not Adequately Controlled With Oral Antidiabetic DrugsCompletedPhase 3Jiangsu HengRui Medicine Co., Ltd.NCT05699408Written as Insulin Glargine
Showing 20 of 146.
Codes
What other systems call Insulin Glargine · ClinicalTrials.gg INT006562
- MeSH (NLM) D000069036Insulin GlargineConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 2ZM8CX04RZINSULIN GLARGINEConfirmed FDA, NLM, Wikidata
- RxNorm 274783Confirmed FDA, Wikidata
- Wikidata Q417317insulin glargineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C47564Insulin GlargineOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000069036 | Insulin Glargine | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 2ZM8CX04RZ | INSULIN GLARGINE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 274783 | — | Confirmed FDA, Wikidata |
| Wikidata | Q417317 | insulin glargine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C47564 | Insulin Glargine | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.